Journal profile · Medicine-Oncology

Libri Oncologici

ISSN 0300-8142 · eISSN 2584-3826 · Zagreb Urednistvo Libri Oncologici · Croatia

Libri Oncologici: diamond open access (no APC); no APC; review about 8 weeks (community reports); 28 articles in 2025; indexed in Scopus.

Impact factor—No published value
CAS zone—Not in the CAS Journal Ranking
CiteScore quartileQ4Oncology · rank 392/428
Review timeabout 8 weeksCommunity average; too few article dates (1)
APCNo APCDiamond open access (no APC)
Acceptance—No reports yet
Articles per year282025 · OpenAlex count

Scope

Aims, scope and focus

Libri Oncologici is published by Zagreb Urednistvo Libri Oncologici. By OpenAlex counts of its recent articles, its largest topics are Breast Cancer Treatment Studies, Breast Lesions and Carcinomas and Colorectal Cancer Surgical Treatments, together about 28.5% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)

Libri oncologici, Croatian Journal of Oncology, is an oncological journal, published by the University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.

From the journal's Aims & Scope

Research area (LetPub): Medicine-Oncology

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology13%
  2. Breast Lesions and CarcinomasMedicine9.1%
  3. Colorectal Cancer Surgical TreatmentsMedicine6.4%
  4. Endometrial and Cervical Cancer TreatmentsMedicine6.1%
  5. Ovarian cancer diagnosis and treatmentMedicine5.5%
  6. Cancer Immunotherapy and BiomarkersMedicine5.3%
  7. Colorectal Cancer Screening and DetectionMedicine5.3%
  8. MRI in cancer diagnosisMedicine4.7%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Not covered

Not covered by this edition.

CAS Xinrui Journal Ranking (March 2026)Not covered

Not covered by this edition.

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

CiteScore quartiles (Scopus, June 2026 release)

SubjectQuartileRankPercentile
OncologyQ4392/428—

Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub

Database indexing

ScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

CiteScore 2026-06
0.4LetPub ·
SJR 2026-06
0.11LetPub ·
SNIP 2026-06
0.06LetPub ·
h-index
5OpenAlex ·
i10-index
0OpenAlex ·
2-year mean citedness
0.15OpenAlex ·
Share of gold OA articles
0%LetPub ·

Articles by year OpenAlex count · 270 in total · the current year is incomplete

YearArticlesOpen accessCitations
2026151512
2025282817
2024232314
20237725
2022252514
202129299

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

Too few articlesOnly 1 articles from the last 24 months carry both submission and acceptance dates, too few for a median

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
about 8 weeksLetPub ·
Submission to publication (journal-reported)
about 12 weeksDOAJ ·
Peer review
Double anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Diamond open access (no APC)DOAJ

Every article is open access and authors pay no article processing charge.

SourceAPCFee waiverLicenseObserved
DOAJNo APCNoCC BY-NC-ND
LetPubNo APCYes—
Publisher websiteNo APC——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
Zagreb Urednistvo Libri Oncologici
Country or region
Croatia
Language
English
ISSN
0300-8142
Electronic ISSN
2584-3826
Official links

FAQ

Frequently asked questions about Libri Oncologici

How long does peer review take at Libri Oncologici?

Authors report an average review time of about 8 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index Libri Oncologici?

According to LetPub and DOAJ records, Libri Oncologici is indexed in Scopus and DOAJ.

Is Libri Oncologici open access, and what is the APC?

Libri Oncologici is a diamond open-access journal (no APC). It charges no article processing charge.

Sources and updates

The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .